Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "CCO"

1760 News Found

Johnson & Johnson brings India’s first PFA technology for atrial fibrillation treatment
Medical Device | June 03, 2026

Johnson & Johnson brings India’s first PFA technology for atrial fibrillation treatment

New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure


Cipla launches India's first sputum inflammometry lab in Mumbai
Healthcare | June 03, 2026

Cipla launches India's first sputum inflammometry lab in Mumbai

The facility sets a new benchmark in respiratory diagnostics


CORONA Remedies receives EU-GMP certification for hormone facility
News | June 02, 2026

CORONA Remedies receives EU-GMP certification for hormone facility

Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets


Europe Treponema pallidum tests market to grow at 3% CAGR through 2036
Healthcare | June 01, 2026

Europe Treponema pallidum tests market to grow at 3% CAGR through 2036

Increasing syphilis cases, stronger STI surveillance initiatives, and growing emphasis on early diagnosis are expected to support sustained demand


Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections
Drug Approval | June 01, 2026

Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections

The approval marks a major milestone in the global fight against antimicrobial resistance


Pfizer’s drug combo shows strong survival results in aggressive prostate cancer trial
Clinical Trials | June 01, 2026

Pfizer’s drug combo shows strong survival results in aggressive prostate cancer trial

This marks one of the most closely watched oncology readouts at this year’s medical congress


International scientists say deuterium research could reshape medicine
R&D | June 01, 2026

International scientists say deuterium research could reshape medicine

The conference highlighted research suggesting that deuterium levels may influence key biological processes


Pfizer's LORBRENA delivers landmark seven-year survival results in advanced lung cancer trial
Clinical Trials | May 30, 2026

Pfizer's LORBRENA delivers landmark seven-year survival results in advanced lung cancer trial

The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer


FDA greenlights AstraZeneca’s Imfinzi combo in bladder cancer breakthrough
R&D | May 30, 2026

FDA greenlights AstraZeneca’s Imfinzi combo in bladder cancer breakthrough

The study tracked patients for more than five years (median 60.7 months), with protection against disease returning emerging in under four months and continuing long term